Literature DB >> 16996840

Skin cholesterol adds to Framingham risk assessment.

Dennis L Sprecher1, Gregory L Pearce.   

Abstract

INTRODUCTION: It has been demonstrated that skin tissue cholesterol (SkinTc) is associated with angiographic disease. Now, we further delineate the relative risk of multivessel disease (>50% stenosis in at least two vessels) in the conjoint presence of high SkinTc and high traditional risk burden.
METHODS: Patients scheduled for angiography (N = 649) had SkinTc measured immediately prior to the procedure. Patients were classified according to the presence of high (>110) SkinTc and high (>10) Framingham global risk scores. Multivariable logistic regression models were used to estimate relative risk of multivessel disease for patients with isolated high skin tissue cholesterol, isolated high Framingham risk or conjoint high skin tissue cholesterol and high Framingham risk (each compared to neither factor elevated).
RESULTS: The mean age was 63 +/- 12 years and 33% (n = 214) were women. Thirty seven percent (n = 237) had angiographically determined multivessel disease. Patients with isolated high SkinTc showed a relative risk of multivessel disease of 1.6 (95% CI = 1.0-2.4), while patients with isolated high Framingham risk had an odds ratio of 1.8 (CI = 1.0-3.4). However, when both scores were elevated, risk of multivessel disease was increased 4.3 times (CI = 2.6-7.2) compared to neither elevated.
CONCLUSIONS: We see an independent, additive risk of concurrent multivessel disease when Framingham risk and skin cholesterol are both elevated. Skin tissue cholesterol may have value in further stratifying subjects with Framingham scores >10.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996840     DOI: 10.1016/j.ahj.2006.04.027

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

1.  A novel fluorescent digitonin derivative for non-invasive skin cholesterol detection: potential application in atherosclerosis screening.

Authors:  Jingshu Ni; Yong Liu; Haiou Hong; Xiangyong Kong; Yongsheng Han; Lei Zhang; Yang Zhang; Yuanzhi Zhang; Changyi Hua; Quanfu Wang; Xia Wang; Yao Huang; Wang YiKun; Dong Meili
Journal:  RSC Adv       Date:  2022-06-22       Impact factor: 4.036

2.  Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements.

Authors:  Jiacheng Lai; Yongsheng Han; Chongjian Huang; Bin Li; Jingshu Ni; Meili Dong; Yikun Wang; Qingtong Wang
Journal:  Lipids Health Dis       Date:  2021-10-17       Impact factor: 3.876

3.  Development of a non-invasive method for skin cholesterol detection: pre-clinical assessment in atherosclerosis screening.

Authors:  Jingshu Ni; Haiou Hong; Yang Zhang; Shiqi Tang; Yongsheng Han; Zhaohui Fang; Yuanzhi Zhang; Nan Zhou; Quanfu Wang; Yong Liu; Zhongsheng Li; YiKun Wang; Meili Dong
Journal:  Biomed Eng Online       Date:  2021-06-01       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.